GSK/Vertex Lexiva Clears FDA With Food-Free Dosing, Broad Indication
Executive Summary
GlaxoSmithKline will likely focus on the dosing flexibility of Lexiva (fosamprenavir), including the option to take with or without food, in its marketing of the protease inhibitor